Raghothama Chaerkady is a globally recognized leader in clinical and quantitative proteomics. Trained in biochemistry and advanced through postdoctoral work at Johns Hopkins University School of Medicine, he co-authored the landmark 2014 Nature human proteome draft that fundamentally reshaped our understanding of the human proteome. A pioneer in LC–MS/MS innovation, PTM biology, immunopeptidomics, and bioinformatics integration, he has published 100+ papers with over 20,000 citations (h-index 55). After nine years leading multi-omics drug discovery at AstraZeneca, he has served as Vice President of Proteomics at Complete Omics since 2023, driving next-generation clinical proteomics and platform excellence.
Ibelieve clinical proteomics transforms patient care by quantifying biology at scale, translating complex molecular signals into reproducible, actionable insights that enable earlier diagnosis, precise stratification, and confident therapeutic decision-making.
My focus is building rigorous, standardized assays that bridge discovery and practice, ensuring robustness, depth, and clinical utility, so proteomics becomes a trusted, routine engine for precision medicine worldwide globally.
Biography
Pioneering leaders in clinical proteomics, translating deep scientific innovation into robust, clinically deployable assays.
Contact Form